Advances in Rheumatology

Papers
(The H4-Index of Advances in Rheumatology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Maintained activity in ankylosing spondylitis patients treated with TNFi and/or NSAID for at least 12 weeks: a cross-sectional study in Brazil27
Could ultrasound and muscle elastography be associated with clinical assessment, laboratory and nailfold capillaroscopy in juvenile dermatomyositis patients?19
Takayasu’s arteritis associated with tuberculosis: a retrospective study18
Effect of curcumin on the expression of NOD2 receptor and pro-inflammatory cytokines in fibroblast-like synoviocytes (FLSs) of rheumatoid arthritis (RA) patients18
Brazilian guidelines for the management of tuberculosis infection in immune-mediated inflammatory diseases: is retesting in latent tuberculosis screening appropriate and Safe?18
Efficacy of two doses of intra-articular ozone therapy for pain and functional mobility in knee osteoarthritis: a double-blind randomized trial18
Official Position of the Brazilian Association of Bone Assessment and Metabolism (ABRASSO) on the evaluation of body composition by densitometry—part II (clinical aspects): interpretation, reporting, 18
A brazilian nationwide multicenter study on deficiency of deaminase-2 (DADA2)17
Comparative study of two laboratory techniques for the detection of HLA-B27 in patients with axial spondyloarthritis: a cross-sectional analysis16
COVID-19 vaccination of patients with chronic immune-mediated inflammatory disease16
“In Memoriam” – Rosa Maria Rodrigues Pereira (1958 – 2022)15
Systemic lupus erythematosus and risk factors for adverse outcomes in pregnancy: a single center retrospective cohort study in Northern Brazil15
Syndecan-4 is correlated with disease activity and serological characteristic of rheumatoid arthritis14
Role of type 2 ryanodine receptor stabilisation in autoimmune cell modulation14
0.16202092170715